Ultralife Valuation
| ULBI Stock | USD 8.73 0.32 3.80% |
At this time, the company appears to be undervalued. Ultralife has a current Real Value of $9.88 per share. The regular price of the company is $8.73. Our model measures the value of Ultralife from inspecting the company fundamentals such as Return On Equity of 0.0593, shares outstanding of 16.45 M, and Operating Margin of 0.08 % as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Ultralife's valuation include:
Price Book 1.1748 | Enterprise Value 161.9 M | Enterprise Value Ebitda 10.8128 | Price Sales 0.9291 | Forward PE 16.1812 |
Undervalued
Today
Please note that Ultralife's price fluctuation is slightly risky at this time. Calculation of the real value of Ultralife is based on 3 months time horizon. Increasing Ultralife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Ultralife is useful when determining the fair value of the Ultralife stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Ultralife. Since Ultralife is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ultralife Stock. However, Ultralife's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.73 | Real 9.88 | Target 12.0 | Hype 8.51 |
The real value of Ultralife Stock, also known as its intrinsic value, is the underlying worth of Ultralife Company, which is reflected in its stock price. It is based on Ultralife's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Ultralife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ultralife's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ultralife helps investors to forecast how Ultralife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ultralife more accurately as focusing exclusively on Ultralife's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ultralife's intrinsic value based on its ongoing forecasts of Ultralife's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ultralife's closest peers. When choosing an evaluation method for Ultralife, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Ultralife Investments |
|
Ultralife Valuation Trend
Knowing Ultralife's actual value is paramount for traders to make sound investment determinations. Ultralife's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Ultralife's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Ultralife's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Ultralife Market Cap
Ultralife is rated second in market capitalization category among related companies. Market capitalization of Industrials industry is at this time estimated at about 373.14 Million. Ultralife totals roughly 138.36 Million in market capitalization claiming about 37% of equities under Industrials industry.Ultralife Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Ultralife's current stock value. Our valuation model uses many indicators to compare Ultralife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ultralife competition to find correlations between indicators driving Ultralife's intrinsic value. More Info.Ultralife is rated first in price to earning category among related companies. It is rated first in price to book category among related companies fabricating about 0.08 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Ultralife is roughly 11.86 . The current Price To Book Ratio is estimated to decrease to 0.84. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ultralife by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ultralife's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ultralife's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ultralife's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ultralife and how it compares across the competition.
About Ultralife Valuation
The stock valuation mechanism determines the current worth of Ultralife on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Ultralife. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ultralife based exclusively on its fundamental and basic technical indicators. By analyzing Ultralife's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Ultralife's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ultralife. We calculate exposure to Ultralife's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ultralife's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 38.3 M | 20.4 M | |
| Pretax Profit Margin | 0.06 | 0.06 | |
| Operating Profit Margin | 0.06 | 0.06 | |
| Net Profit Margin | 0.05 | 0.05 | |
| Gross Profit Margin | 0.24 | 0.16 |
8 Steps to conduct Ultralife's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ultralife's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ultralife's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ultralife's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ultralife's revenue streams: Identify Ultralife's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ultralife's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ultralife's growth potential: Evaluate Ultralife's management, business model, and growth potential.
- Determine Ultralife's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ultralife's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ultralife Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Ultralife does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 16.2 M | |
| Quarterly Earnings Growth Y O Y | 5.898 | |
| Forward Price Earnings | 16.1812 |
Ultralife Current Valuation Indicators
Valuation refers to the process of determining the present value of Ultralife and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ultralife we look at many different elements of the entity such as Ultralife's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Ultralife's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Ultralife's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ultralife, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ultralife's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ultralife's worth.When determining whether Ultralife offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ultralife's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ultralife Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ultralife Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.Note that the Ultralife information on this page should be used as a complementary analysis to other Ultralife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Ultralife Stock analysis
When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Ultralife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.898 | Earnings Share 0.44 | Revenue Per Share 9.785 | Quarterly Revenue Growth 0.234 | Return On Assets 0.0342 |
The market value of Ultralife is measured differently than its book value, which is the value of Ultralife that is recorded on the company's balance sheet. Investors also form their own opinion of Ultralife's value that differs from its market value or its book value, called intrinsic value, which is Ultralife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultralife's market value can be influenced by many factors that don't directly affect Ultralife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.